Burkhard Becher Selected Research

Colitis

6/2021	Macrophages Compensate for Loss of Protein Tyrosine Phosphatase N2 in Dendritic Cells to Protect from Elevated Colitis.
1/2020	Extracorporeal Photopheresis for Colitis Induced by Checkpoint-Inhibitor Therapy.
1/2016	Epithelial IL-23R Signaling Licenses Protective IL-22 Responses in Intestinal Inflammation.
4/2015	Helicobacter pylori-specific protection against inflammatory bowel disease requires the NLRP3 inflammasome and IL-18.
8/2012	IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells.
1/2009	RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Burkhard Becher Research Topics

Disease

40	Inflammation (Inflammations) 10/2021 - 08/2002
17	Multiple Sclerosis 01/2022 - 08/2002
15	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 08/2002
14	Neoplasms (Cancer) 01/2021 - 11/2010
13	Neuroinflammatory Diseases 01/2022 - 02/2008
10	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 08/2002
8	Psoriasis (Pustulosis Palmaris et Plantaris) 10/2021 - 06/2012
6	Colitis 06/2021 - 01/2009
5	Infections 01/2022 - 07/2011
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2021 - 08/2012
5	Atherosclerosis 01/2020 - 11/2004
4	Leukemia 10/2020 - 01/2018
4	Demyelinating Diseases (Demyelinating Disease) 01/2019 - 12/2006
3	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2020
3	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2017
2	Respiratory Hypersensitivity 01/2021 - 08/2011
2	COVID-19 01/2021 - 01/2020
2	Lung Diseases (Lung Disease) 01/2021 - 01/2011
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2021
2	Asthma (Bronchial Asthma) 01/2021 - 08/2011
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 01/2018
2	Glioma (Gliomas) 01/2020 - 12/2013
2	Sepsis (Septicemia) 10/2019 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2019 - 11/2018
2	Autoimmune Diseases of the Nervous System 01/2019 - 08/2002
2	Narcolepsy 10/2018 - 11/2016
2	Sleep Wake Disorders 10/2018 - 11/2016
2	Central Nervous System Diseases (CNS Diseases) 01/2018 - 01/2009
2	Alzheimer Disease (Alzheimer's Disease) 06/2015 - 12/2012
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Persistent Infection 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Myasthenia Gravis 01/2021

Drug/Important Bio-Agent (IBA)

27	CytokinesIBA 01/2022 - 08/2002
20	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022 - 06/2011
14	Interleukin-12 (IL 12)IBA 10/2021 - 08/2002
14	Interleukin-23 (Interleukin 23)IBA 12/2019 - 10/2003
8	AntigensIBA 01/2021 - 03/2005
8	Interleukin-17 (Interleukin 17)IBA 01/2020 - 10/2007
6	Interleukin-22 (IL-22)IBA 12/2018 - 10/2007
5	InterferonsIBA 01/2022 - 06/2010
5	Imiquimod (Aldara)FDA LinkGeneric 10/2021 - 06/2012
5	InterleukinsIBA 01/2021 - 09/2006
4	AntibodiesIBA 01/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 11/2016
3	Peptides (Polypeptides)IBA 01/2021 - 01/2019
3	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2021 - 06/2013
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 01/2009
3	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
3	Interleukin-2 (IL2)IBA 01/2019 - 11/2015
3	Interleukin-15 (Interleukin 15)IBA 04/2018 - 01/2018
2	AutoantigensIBA 01/2022 - 08/2007
2	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2020
2	Clodronic Acid (Clodronate)IBA 06/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 08/2015
2	AutoantibodiesIBA 01/2021 - 12/2006
2	Fc Receptors (Fc Receptor)IBA 01/2021 - 12/2006
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2021 - 06/2013
2	LipidsIBA 01/2020 - 11/2004
2	Scavenger Receptors (Scavenger Receptor)IBA 01/2020 - 11/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2019 - 08/2011
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2015
2	OrexinsIBA 10/2018 - 11/2016
2	HLA-DQB1 antigen (HLA DQB1)IBA 10/2018 - 11/2016
2	Sorafenib (BAY 43-9006)FDA Link 04/2018 - 01/2018
2	LigandsIBA 11/2017 - 09/2006
2	Diphtheria ToxinIBA 06/2015 - 04/2015
2	Amyloid (Amyloid Fibrils)IBA 06/2015 - 12/2012
2	Interleukin-18 (Interleukin 18)IBA 04/2015 - 09/2006
2	oxidized low density lipoproteinIBA 10/2014 - 05/2010
2	Apolipoproteins E (ApoE)IBA 10/2014 - 11/2004
2	AllergensIBA 08/2011 - 01/2011
1	Dimethyl FumarateIBA 01/2022
1	Interleukin-23 Subunit p19IBA 10/2021
1	Protein Tyrosine PhosphatasesIBA 06/2021
1	Histocompatibility Antigens Class IIIBA 01/2021
1	Green Fluorescent ProteinsIBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	cytochrome b245IBA 01/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor Receptors (GM-CSF Receptor)IBA 01/2021
1	Biological ProductsIBA 01/2021
1	IntegrinsIBA 01/2021
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Cholinergic ReceptorsIBA 01/2021
1	Interleukin-10 ReceptorsIBA 01/2021
1	epidermal growth factor receptor VIIIIBA 01/2021
1	NADP (NADPH)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	SteroidsIBA 01/2021

Therapy/Procedure

14	Therapeutics 01/2021 - 01/2009
7	Immunotherapy 01/2021 - 11/2015
3	Cell Transplantation 10/2019 - 01/2018
1	Heterologous Transplantation (Xenotransplantation) 01/2021